Secure and scalable data sharing is essential for collaborative clinical decision making. Conventional clinical data efforts are often siloed, however, which creates barriers to efficient information exchange and impedes effective treatment decision made for patients. This paper provides four contributions to the study of applying blockchain technology to clinical data sharing in the context of technical requirements defined in the “Shared Nationwide Interoperability Roadmap” from the Office of the National Coordinator for Health Information Technology (ONC). First, we analyze the ONC requirements and their implications for blockchain-based systems. Second, we present FHIRChain, which is a blockchain-based architecture designed to meet ONC requirements by encapsulating the HL7 Fast Healthcare Interoperability Resources (FHIR) standard for shared clinical data. Third, we demonstrate a FHIRChain-based decentralized app using digital health identities to authenticate participants in a case study of collaborative decision making for remote cancer care. Fourth, we highlight key lessons learned from our case study.
Although complex-valued (CV) neural networks have shown better classification results compared to their realvalued (RV) counterparts for polarimetric synthetic aperture radar (PolSAR) classification, the extension of pixel-level RV networks to the complex domain has not yet thoroughly examined. This paper presents a novel complex-valued deep fully convolutional neural network (CV-FCN) designed for PolSAR image classification. Specifically, CV-FCN uses PolSAR CV data that includes the phase information and utilizes the deep FCN architecture that performs pixel-level labeling. It integrates the feature extraction module and the classification module in a united framework. Technically, for the particularity of PolSAR data, a dedicated complex-valued weight initialization scheme is defined to initialize CV-FCN. It considers the distribution of polarization data to conduct CV-FCN training from scratch in an efficient and fast manner. CV-FCN employs a complex downsampling-then-upsampling scheme to extract dense features. To enrich discriminative information, multi-level CV features that retain more polarization information are extracted via the complex downsampling scheme. Then, a complex upsampling scheme is proposed to predict dense CV labeling. It employs complex max-unpooling layers to greatly capture more spatial information for better robustness to speckle noise. In addition, to achieve faster convergence and obtain more precise classification results, a novel average cross-entropy loss function is derived for CV-FCN optimization. Experiments on real PolSAR datasets demonstrate that CV-FCN achieves better classification performance than other state-of-art methods.Index Terms-Complex-valued deep fully convolutional neural network (CV-FCN), polarimetric synthetic aperture radar (Pol-SAR) image classification, pixel-level labeling.
We report a high resolution and low-dose scanning electron nanodiffraction (SEND) technique for nanostructure analysis. The SEND patterns are recorded in a transmission electron microscope (TEM) using a low-brightness ∼2 nm electron beam with a LaB6 thermionic source obtained by a large demagnification of the condenser 1 lens. The diffraction pattern is directly recorded using a CCD camera optimized for low-dose imaging. A custom script was developed for calibration and automated data acquisition. The performance of low-dose SEND is evaluated using nanostructured Au as a test sample for the quality of diffraction patterns, sample stability and probe size. We demonstrate that our method provides an effective and robust way for recording diffraction patterns from nanometer-sized grains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.